International Conference on Hybrid Imaging (IPET 2024)

IPET 2024: Advancing Frontiers in Hybrid Imaging for Precision Medicine

Purpose and Objectives:

• To comprehensively review and assess the role of streamlined and emerging medical imaging techniques, with a particular emphasis on hybrid imaging (SPECT-CT, PET-CT and PET-MR), while providing best practices for the clinical management of patients with cancer;
• To critically evaluate – by employing an evidence-based approach – the current clinical indications for radiopharmaceutical therapies in cancer management. This involves assessing the efficacy and appropriateness of such therapies in various clinical scenarios;
• To enhance the quality of clinical practice through immersive 'read with the experts' sessions and robust discussions. These interactive sessions are designed to refine participants’ skills and promote an in-depth understanding of complex cases;
• To foster engagement with the user community, which encompasses nuclear medicine physicians, radiologists, radiation oncologists, clinical oncologists, medical physicists, technologists, radiographers, radiopharmacists, radiochemists and other scientists working across the spectrum of hybrid imaging. The conference seeks to provide these professionals with pivotal insights on the field’s latest advancements.
• To provide participants with essential theoretical tools related to ethics, leadership, education and patient advocacy. This will empower attendees to assume leadership roles in the domain of medical imaging, thereby shaping the discipline’s future landscape;
• To facilitate the exchange of cutting-edge information within the realm of radiopharmaceutical sciences. Participants will have the opportunity to share and gain insights into the latest research, developments and trends within this dynamic field; and
• To conduct an in-depth review of the technological strides which have been made in hybrid medical imaging equipment. Through covering advances in hardware, software and methodologies, this will enable participants to stay abreast of the latest technological breakthroughs.

 Themes and Topics:

The IAEA invites participants to provide high-quality contributions on all aspects of nuclear medicine, diagnostic imaging or theranostic applications and research. Academic and practice-based papers that fall within the following topics will be welcomed:

1. Applications of PET-CT, molecular imaging and diagnostic imaging for different types of cancer: breast, lung, colorectal, prostate, neuroendocrine, thyroid etc.;
2. Theranostic applications;
3. Radio-guided surgery;
4. Hybrid imaging and other imaging techniques in benign conditions;
5. Dosimetry, physics and instrumentation;
6. Radiopharmaceutical production, including good manufacturing practices and quality assurance;
7. Radiation protection for personnel and patients;
8. Quality management in nuclear medicine and diagnostic imaging;
9. Ethics, leadership and education for nuclear medicine and diagnostic imaging professionals; and
10. Experience in establishing or strengthening nuclear medicine, diagnostic imaging or radionuclide therapy facilities, including related technical cooperation projects.

Call for Papers:

Contributions on the topics listed in Section C are welcome as oral or poster presentations. All submissions, apart from invited papers, must present original work, which has not been published elsewhere.

Abstracts in English (approximately 500 words (including title) on one or maximum of two A4 pages should not include more than one figure, graph or table; should not include references; should give enough information on the content of the proposed paper, using the headings; background, methodology, results, conclusion to enable the Programme Committee to evaluate it. The abstract can be submitted through this system from 22 December 2023 until 11 March 2024.

Registration through the InTouch+ platform:

All persons wishing to participate in the event must be designated by an IAEA Member State or should be a member of an organization that has been invited to attend. 

Access the InTouch+ platform (https://intouchplus.iaea.org)

Deadlines: